Ann: CEO's Address to AGM, page-2

I had to check my eyesight - 0% growth. Competition (both Theraspheres and alternate salvage treatments) must be intense. I doubt very much the docs around the world care much about the issues at Sirtex, when they are confronted with dying patients every day.

Also with the cost outs, and reduction in R and D spend - I thought CC profits should be up about 20%.